The low expression of CDK5RAP3 led to a significant increase in CD206+ cells and a decrease in CD16/32+ cells in tumour tissues, while the high expression of CDK5RAP3 led to a decrease in CD206+ cells and an increase in CD16/32+ cells (Fig. 2B). The gene discussed is MRC1; the disease is neoplasm.